GAPDH served as an internal control
doi: 10.3389/fphar.2024.1471615 Received 28 July 2024 Accepted 10 October 2024 Published 22 October 2024 Volume 15 - 2024 Edited by Felice Strollo, Endocrinology and Metabolism Unit, IRCCS San Raffaele Pisana, Rome, Italy, Italy Reviewed by Sandro Gentile, University of Campania Luigi Vanvitelli, Italy Maja Cigrovski Berkovic, Clinical Hospital Dubrava, Croatia Updates Copyright 2024 Zhang, Wang and Zhou
It is not currently funded by Pharmac so patients will have to pay for the treatment themselves
One carton should last a month
Monthly Monitoring and Ongoing Support Monthly check-ins include body composition tracking and lab reviews calibrated to how your metabolism is responding
Certain medical conditions, health histories, and life situations can make the use of semaglutide unsafe